
WOODCLIFF LAKE, N.J., June 4 (UPI) -- U.S. drug makers Barr and Eli Lilly said Monday they have voluntarily dismissed their patent dispute over Prozac Weekly Capsules.
Lilly filed the patent suit against Barr last May in an Indiana district court, to prevent Barr from marketing a generic version of the Prozac Weekly formulation. In the case, Lilly asserted a re-issue patent on the anti-depressant it was awarded in March 2005.
As a result of the voluntary dismissal of the case, Barr is free to seek approval of its generic formulation of Prozac Weekly, and said it believes it is the first company to file for approval of the product and would be eligible for six months' market exclusivity if OK'd.
Barr said sales of Prozac Weekly were about $30 million, for the 12 months ending March 2007, based on data from IMS Health.
|
|
|
|
|
|
| Additional Health News Stories | |
WASHINGTON, May 27 (UPI) --
President Obama has put U.S. foreign policy on auto-pilot while he concentrates on getting re-elected, a senior Republican senator said Sunday.
|
'Men in Black' leads U.S. box office ... Michelle Obama, daughters see Beyonce ... Lady Gaga cancels Jakarta gig for security ... Madonna asks for pool at Israel venue ... News from United Press International.
|
ANCHORAGE, Alaska, May 27 (UPI) --
A black bear didn't go over a river but went to the woods after scampering through residential and industrial areas of Anchorage, Alaska, police said.
|
To avoid a meltdown in 2006, Ford Motor Co. mortgaged the farm putting up its assets – including its Blue Oval logo, and F-150 pickup and iconic Mustang trademarks – to secure $23.5 billion in credit.
|
| Stories | Photos | People | Comments |
View Caption